ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
35.64
0.08%
US Tech 100
18,078.00
-0.21%
S&P 500
5,297.10
-0.21%
US Dollar vs CAD
1.36227
0.05%
Bitcoin
65,192.82
-0.07%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Ovid Therapeutics Inc (OVID)

  7. Ovid Therapeutics Inc (OVID) News

OVID

Ovid Therapeutics (OVID)

Ovid Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:OVID
DateTimeSourceHeadlineSymbolCompany
05/14/20244:19PMEdgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:OVIDOvid Therapeutics Inc
05/14/20247:11AMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:OVIDOvid Therapeutics Inc
05/14/20247:03AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:OVIDOvid Therapeutics Inc
05/14/20247:00AMGlobeNewswire Inc.Ovid Therapeutics Reports Business Updates and First Quarter 2024 Financial ResultsNASDAQ:OVIDOvid Therapeutics Inc
05/13/20246:00AMGlobeNewswire Inc.Ovid Therapeutics to Present at the H.C. Wainwright 2nd Annual BioConnect Investor ConferenceNASDAQ:OVIDOvid Therapeutics Inc
04/04/20247:00AMGlobeNewswire Inc.Ovid Therapeutics to Present at the 23rd Annual Needham Virtual Healthcare ConferenceNASDAQ:OVIDOvid Therapeutics Inc
03/08/20247:24AMEdgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:OVIDOvid Therapeutics Inc
03/08/20247:20AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:OVIDOvid Therapeutics Inc
03/08/20247:00AMGlobeNewswire Inc.Ovid Therapeutics Reports Business Updates, Fourth Quarter and Full Year 2023 Financial ResultsNASDAQ:OVIDOvid Therapeutics Inc
02/28/20247:00AMGlobeNewswire Inc.Ovid Therapeutics to Present at the TD Cowen 44th Annual Health Care ConferenceNASDAQ:OVIDOvid Therapeutics Inc
02/26/20245:05PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OVIDOvid Therapeutics Inc
02/26/20245:01PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OVIDOvid Therapeutics Inc
02/26/20245:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OVIDOvid Therapeutics Inc
02/26/20244:56PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OVIDOvid Therapeutics Inc
02/26/20244:53PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OVIDOvid Therapeutics Inc
02/14/202410:10AMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:OVIDOvid Therapeutics Inc
02/12/20245:06AMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:OVIDOvid Therapeutics Inc
02/06/20247:00AMGlobeNewswire Inc.Ovid Therapeutics to Present at the Oppenheimer 34th Annual Healthcare Life Sciences ConferenceNASDAQ:OVIDOvid Therapeutics Inc
12/06/20234:08PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:OVIDOvid Therapeutics Inc
12/01/20236:30AMGlobeNewswire Inc.Ovid Therapeutics to Present Five Abstracts Supporting its Epilepsy Programs at the 77th American Epilepsy Society Annual Meeting (2023)NASDAQ:OVIDOvid Therapeutics Inc
11/15/202311:15PMEdgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:OVIDOvid Therapeutics Inc
11/15/20233:11PMEdgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:OVIDOvid Therapeutics Inc
11/03/20233:08PMEdgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:OVIDOvid Therapeutics Inc
11/03/20237:13AMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:OVIDOvid Therapeutics Inc
11/03/20237:10AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:OVIDOvid Therapeutics Inc
11/03/20237:00AMGlobeNewswire Inc.Ovid Therapeutics Reports Third Quarter 2023 Financial Results and Corporate UpdatesNASDAQ:OVIDOvid Therapeutics Inc
10/18/20237:04AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:OVIDOvid Therapeutics Inc
10/18/20237:00AMGlobeNewswire Inc.Ovid Therapeutics and Ligand Pharmaceuticals Enter into a $30 Million Agreement for a 13% Interest in Soticlestat Royalties and Milestones Extending Ovid’s Cash Runway into 2026NASDAQ:OVIDOvid Therapeutics Inc
10/10/20237:00AMGlobeNewswire Inc.Ovid Therapeutics to Present at the Jefferies Biotech CNS/Neuro SummitNASDAQ:OVIDOvid Therapeutics Inc
10/02/202311:15AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:OVIDOvid Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:OVID

Your Recent History

BOV
PETRK321
PETRK321 Ex:29,34
Delayed Upgrade Clock
ADVFN Logo

Canada
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved